To explore the biological functions of intra- and extra-cellular Gal-9 in regulating myeloid cell differentiation in human cancer, we used in vitro experimental systems based on the co-cultivation of CD33+ peripheral leucocytes with NPC cells engineered to express and release various amounts of Gal-9. This evidence concerns the gene CD33 and nasopharyngeal carcinoma.